Clinical Trials
4 trialsNCT02350712 2018-09-11
Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer
Daiichi Sankyo
Phase 1 Completed
NCT01957280 2014-05-14
Study to Assess Pharmacokinetics, Immunogenicity and Safety/Tolerability of Patritumab (U3-1287)
Daiichi Sankyo
Phase 1 Completed
NCT01479023 2013-12-20
Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors
Washington University School of Medicine
Phase 1 Terminated
NCT00730470 2010-07-29
Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors
U3 Pharma GmbH
Phase 1 Completed